Human Genome Sciences Inc's ROI from its second quarter of 2012 to the second quarter of 2011 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Human Genome Sciences Inc's ROI in the second quarter of 2012?
Human Genome Sciences Inc recorded a cumulative net loss of $-356 million during 12 months ending in the second quarter of 2012, resulting in a negative return on investment (ROI) of -26.44%.

Within the Healthcare sector 39 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2012 from to 614.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter	(Jun 30 2011) II. Quarter
Y / Y Investment Change TTM	34.39 %	84.86 %	133.84 %	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	944	1,566	1,898	975	1,041
Return On Investment (TTM)	-26.44 %	-25.09 %	-31.65 %	-31.15 %	-33.97 %
HGSI's Overall Ranking	# 614	#	#	#	#
Seq. Investment Change TTM	-1.77 %	13.74 %	-3.26 %	24.33 %	35.12 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-356	-344	-381	-388	-340

HGSI Company Profile >> Back to HGSI Roi Comparisons >> See Annual HGSI Return On Investment

Return On Investment HGSI's Ranking
Within:	No.
Industry	# 3
Sector	# 40
Overall	# 614

Return On Investment Statistics
High	Average	Low
-39.33 %	-39.33 %	-39.33 %
(Jun 30 2012)

Financial Statements
Human Genome Sciences Inc's II. Quarter Investments	$ 944 Millions	HGSI's Balance sheet
Human Genome Sciences Inc's II. Quarter Income	$ -93 Millions	Quarterly HGSI's Income Statement
HGSI's Income by Division		See HGSI's Income by Division

HGSI Annual Return On Investment	(Dec 31 2009) 2011
Total Investments in Millions	2,060	0	0	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	6	0	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	0.27 %	-	-	-	-

Annual Roi Comment

In the fiscal year 2011 ROI improved to 0.27 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HGSI's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HGSI's Competitors
Subscribers only: Roi for Human Genome Sciences Inc's Suppliers
Subscribers only: Return On Investment for HGSI's Customers

Other Ratios
HGSI's Roa	HGSI's Inventory Turnover Ratio	HGSI's Growth Rates	HGSI's Dividend Statistics
	HGSI's Profitability Ratios	HGSI's Asset Turnover Ratio	HGSI's Dividend Growth
HGSI's Roe	HGSI's Valuation Ratios	HGSI's Financial Strength Ratios	HGSI's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2012, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:07:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.